Building on these context-dependent roles, the mechanism by which FMRP exerts diverse regulatory functions across tumor types likely involves distinct coactivators, such as non-coding RNAs and m6A modification machinery, that modulate its RNA-binding specificity. The gene discussed is FMR1; the disease is neoplasm.